Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Asuragen Inc patents

Recent patent applications related to Asuragen Inc. Asuragen Inc is listed as an Agent/Assignee. Note: Asuragen Inc may have other listings under different names/spellings. We're not affiliated with Asuragen Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Asuragen Inc-related inventors

Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating a/t-rich segments

Described herein are methods, compositions, kits, and uses thereof for analysis of nucleic acid segments comprising a repeating a/t-rich segment, wherein the repeating a/t-rich segment is: (i) a homopolymeric segment comprising at least 10 a residues, at least 10 t residues, or at least 10 u residues, wherein the at least 10 a, t, or u residues are consecutive or interrupted once by one to three other nucleotides; or (ii) a segment comprising (tna)m, (atn)m, (tan)m, or (ant)m, wherein n is 2 or greater and m is such that the length of the repeating a/t-rich segment is 10 or more residues.. . ... Asuragen Inc

Methods and apparatuses for improving mutation assessment accuracy

Embodiments are provided that relate to methods, systems, kits, computer-readable medium, and apparatuses comprising a computer-based variant calling model that incorporates the viable template count of the aliquot in calling a sequence of a target region based on a set of sequence reads.. . ... Asuragen Inc

Methods for nucleic acid size detection of repeat sequences

Disclosed herein are data processing and calculating annotation systems and devices, and corresponding methods, for nucleic acid analysis. In particular, disclosed herein are methods for sizing a repeat region of a nucleic acid sample. ... Asuragen Inc

Methods and compositions involving mirna and mirna inhibitor molecules

The present invention concerns methods and compositions for introducing mirna activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying mirnas with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic mirnas and/or mirna inhibitors are used in library screening assays.. ... Asuragen Inc

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Asuragen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Asuragen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by